Cited 0 times in
Role of the Hippo Pathway in Fibrosis and Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, CL | - |
dc.contributor.author | Choi, SH | - |
dc.contributor.author | Mo, JS | - |
dc.date.accessioned | 2020-10-21T07:21:39Z | - |
dc.date.available | 2020-10-21T07:21:39Z | - |
dc.date.issued | 2019 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/18962 | - |
dc.description.abstract | The Hippo pathway is the key player in various signaling processes, including organ development and maintenance of tissue homeostasis. This pathway comprises a core kinases module and transcriptional activation module, representing a highly conserved mechanism from Drosophila to vertebrates. The central MST1/2-LATS1/2 kinase cascade in this pathway negatively regulates YAP/TAZ transcription co-activators in a phosphorylation-dependent manner. Nuclear YAP/TAZ bind to transcription factors to stimulate gene expression, contributing to the regenerative potential and regulation of cell growth and death. Recent studies have also highlighted the potential role of Hippo pathway dysfunctions in the pathology of several diseases. Here, we review the functional characteristics of the Hippo pathway in organ fibrosis and tumorigenesis, and discuss its potential as new therapeutic targets. | - |
dc.format | application/pdf | - |
dc.language.iso | en | - |
dc.subject.MESH | Adaptor Proteins, Signal Transducing | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Epigenesis, Genetic | - |
dc.subject.MESH | Epithelial-Mesenchymal Transition | - |
dc.subject.MESH | Fibrosis | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Neoplasms | - |
dc.subject.MESH | Phosphorylation | - |
dc.subject.MESH | Protein-Serine-Threonine Kinases | - |
dc.subject.MESH | Transcription Factors | - |
dc.subject.MESH | Tumor Microenvironment | - |
dc.title | Role of the Hippo Pathway in Fibrosis and Cancer | - |
dc.type | Article | - |
dc.identifier.pmid | 31100975 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562634/ | - |
dc.subject.keyword | ECM | - |
dc.subject.keyword | EMT | - |
dc.subject.keyword | LATS1/2 | - |
dc.subject.keyword | MST1/2 | - |
dc.subject.keyword | TAZ | - |
dc.subject.keyword | YAP | - |
dc.subject.keyword | cancer | - |
dc.subject.keyword | fibrosis | - |
dc.subject.keyword | myofibroblast | - |
dc.contributor.affiliatedAuthor | 모, 정순 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.3390/cells8050468 | - |
dc.citation.title | Cells | - |
dc.citation.volume | 8 | - |
dc.citation.number | 5 | - |
dc.citation.date | 2019 | - |
dc.citation.startPage | 468 | - |
dc.citation.endPage | 468 | - |
dc.identifier.bibliographicCitation | Cells, 8(5). : 468-468, 2019 | - |
dc.identifier.eissn | 2073-4409 | - |
dc.relation.journalid | J020734409 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.